A61K 49 - Preparations for testing in vivo

Patents for A61K 49 - Preparations for testing in vivo (35,376)
11/1994
11/30/1994	EP0626390A1 Humanised antibodies
11/30/1994	EP0626389A1 Recombinant antibodies specific for TNF-alpha
11/30/1994	EP0626387A1 Nucleosides and oligonucleotides with 2'-ether groups
11/30/1994	EP0625990A1 Glycoprotein complexes and glycoproteins
11/30/1994	EP0625910A1 Dual carrier immunogenic construct
11/29/1994	US5369101 Expanded porphyrins: large porphyrin-like tripyrroledimethine-derived macrocycles
11/29/1994	US5368840 Natural polymers as contrast media for magnetic resonance imaging
11/29/1994	US5368839 Insoluble salts of lanthanides for the visual display using nuclear magnetic resonance, of the gastro-intestinal tract
11/29/1994	US5368837 X-ray contrast compositions containing an organic crystalline X-ray contrast agent and a cellulose derivative
11/24/1994	WO1994026778A1 Conjugation-stabilized polypeptide compositions
11/24/1994	WO1994026754A1 Bicyclopolyazamacrocyclophosphonic acids, their complexes and conjugates, for use as contrast agents, and processes for their preparation
11/24/1994	WO1994026316A1 Parenterally administerable oil-in-water emulsion for use as an x-ray contrasting agent which is stable under heat-sterilization conditions
11/24/1994	WO1994026314A1 Compounds for cancer imaging and therapy
11/24/1994	WO1994026313A1 Bicyclopolyazamacrocyclocarboxylic acid complexes, their conjugates, processes for their preparation, and use as contrast agents
11/24/1994	WO1994026297A1 Improved detection and therapy of lesions with biotin/avidin-metal chelating protein conjugates
11/24/1994	WO1994026295A1 Metal chelates as spacer compounds in biologically active peptides
11/24/1994	WO1994026294A1 Ligand precursors for incorporation into peptides
11/24/1994	WO1994026276A1 Tricyclopolyazamacrocyclophosphonic acids, complexes and derivatives thereof, for use as contrast agents
11/24/1994	WO1994026275A1 2-pyridylmethylenepolyazamacrocyclophosphonic acids, complexes and derivatives thereof, for use as contrast agents
11/24/1994	WO1994026115A1 Rapid diagnostic procedure for ivermectin resistance
11/24/1994	WO1994020512A3 Analogs for specific oligosaccharide-protein interactions and uses therefor
11/24/1994	CA2163204A1 Rapid diagnostic procedure for ivermectin resistance
11/24/1994	CA2162174A1 2-pyridylmethylenepolyazamacrocyclophosphonic acids, complexes and derivatives thereof, for use as contrast agents
11/24/1994	CA2162172A1 Tricyclopolyazamacrocyclophosphonic acids, complexes and derivatives thereof, for use as contrast agents
11/24/1994	CA2162136A1 Bicyclopolyazamacrocyclophosphonic acids, their complexes and conjugates, for use as contrast agents, and processes for their preparation
11/24/1994	CA2139738A1 Bicyclopolyazamacrocyclocarboxylic acid complexes, their conjugates, processes for their preparation, and use as contrast agents
11/24/1994	CA2139503A1 Compounds for cancer imaging and therapy
11/23/1994	EP0625263A1 Contrast agents useful for both x-ray and mri
11/23/1994	EP0625200A1 Biosynthetic binding protein for cancer marker
11/23/1994	EP0625068A1 Highly fluorinated, chloro-substituted organic compound-containing emulsions and methods of making and using them
11/23/1994	EP0625055A1 Use of fullerenes in diagnostic and/or therapeutic agents
11/22/1994	US5367080 Pyridine derivatives
11/22/1994	US5367058 Modified antibodies with increased affinity
11/22/1994	US5367056 Endothelial cell-leukocyte adhesion molecules (ELAMs) and molecules involved in leukocyte adhesion (MILAs)
11/22/1994	US5366722 Contrast media comprising a non-ionic contrast agent and sodium ions
11/22/1994	US5366721 Method for detection of long-lived radioisotopes in small biochemical samples
11/22/1994	US5365948 Method for use in treating a patient with FK 506 to prevent an adverse immune response
11/17/1994	EP0624097A1 Targeting radioactive immunoreagents
11/16/1994	CN1094938A Methods for the in vivo measurement of the concentration of nmr-detect able xenobiotic compounds
11/15/1994	US5364953 High relaxivity, paramagnetic, metal clusters for magnetic resonance imaging
11/15/1994	US5364614 Cascade polymer bound chelating compounds, their chelates and conjugates, processes for their production, and pharmaceutical agents containing them
11/15/1994	US5364613 Polychelants containing macrocyclic chelant moieties
11/15/1994	US5363846 Method for the diagnosis and treatment of inflammation
11/10/1994	WO1994025627A1 Methods of treating and detecting cancer using viruses
11/10/1994	WO1994025626A1 Dna profiles as an indicator of cellular redox potential and cancer risk
11/10/1994	WO1994025075A1 Polymeric x-ray contrast compositions containing iodinated polymeric beads
11/10/1994	WO1994025074A1 Method of evaluating chemotherapeutic agents in vivo
11/10/1994	WO1994017193A3 Chimeric l- and p-selectin by exchange of domains - uses thereof
11/10/1994	CA2161671A1 Methods of treating and detecting cancer using viruses
11/10/1994	CA2161531A1 Dna profiles as an indicator of cellular redox potential and cancer risk
11/10/1994	CA2161434A1 Polymeric x-ray contrast compositions containing iodinated polymeric beads
11/09/1994	EP0623215A1 Methods and compositions for diagnosing cat scratch disease and bacillary angiomatosis
11/09/1994	EP0623134A1 Metal complexes of water soluble texaphyrins
11/08/1994	US5362757 Administering for treatment of cardiovascular disorders while reducing side effects
11/08/1994	US5362478 Magnetic resonance imaging with fluorocarbons encapsulated in a cross-linked polymeric shell
11/08/1994	US5362477 Imaging the organs and tissues; enhanced relaxation properties
11/08/1994	US5362476 Contrast agents for magnetic resonance imaging
11/08/1994	US5362475 Salt of gadolinium diethylenetriaminepentaacetic acid (gadofosveset salt)
11/08/1994	US5362474 Method for detecting and locating inflammatory or tumor foci in a patient and diagnostic kit therefor
11/02/1994	CN1094312A X-ray contrast medium used for checking of large and small intestine
11/01/1994	US5360604 X-ray contrast compositions containing an organic crystalline X-ray contrast agent in combination with pharmaceutically acceptable clays
11/01/1994	US5359945 Balanced pressure solid fuel heating unit
10/1994
10/27/1994	WO1994023759A1 Improved detection and therapy of lesions with biotin/avidin polymer conjugates
10/27/1994	WO1994023756A1 Neural thread protein gene expression and detection of alzheimer's disease
10/27/1994	WO1994023649A1 Treated calcium/oxyanion-containing particles for medical diagnostic imaging
10/27/1994	WO1994023646A1 Stabilization of voltage sensitive dyes
10/27/1994	WO1994023572A1 Cell culturing method and medium
10/27/1994	CA2161109A1 Improved detection and therapy of lesions with biotin/avidin polymer conjugates
10/27/1994	CA2161097A1 Neural thread protein gene expression and detection of alzheimer's disease
10/27/1994	CA2159804A1 Cell culturing method and medium
10/27/1994	CA2159799A1 Treated calcium/oxyanion-containing particles for medical diagnostic imaging
10/26/1994	EP0621491A2 Methods for the in vivo measurement of the concentration of NMR-detectable xenobiotic compounds
10/26/1994	EP0620745A1 Improvements in contrast agents, consisting of galactose particles
10/26/1994	EP0620744A1 Improvements in or relating to contrast agents
10/26/1994	EP0620743A1 Contrast agents consisting of galactose particles and an amphiphilic carboxylic acid
10/26/1994	EP0174366B1 T-cell receptor-specific for antigen polypeptides and related polynucleotides
10/26/1994	CN1093902A Solid reagent for penicillin skin test and its production method
10/26/1994	CN1093893A Altered dipole moment magnetic resonance imaging method
10/25/1994	US5359030 Coupling of a peptide and polymer; therapy, diagnosis
10/25/1994	US5358704 Chelates with metals, such as gadolinium
10/25/1994	US5358703 Method for the detection of nitric oxide
10/25/1994	US5358702 Methoxylated gel particle contrast media for improved diagnostic imaging
10/25/1994	US5357959 Altered dipole moment magnetic resonance imaging method
10/19/1994	EP0644775A4 Cocaine receptor binding ligands.
10/19/1994	EP0620447A2 Altered dipole moment magnetic resonance imaging method
10/19/1994	EP0620276A1 Humanised antibodies
10/19/1994	EP0620012A1 X-ray contrast medium for examining large and small intestines
10/19/1994	EP0619744A1 Nonionic x-ray contrast agents, compositions and methods
10/19/1994	EP0619716A1 Contrast media
10/19/1994	EP0449825B1 Improved emulsions of highly fluorinated organic compounds
10/18/1994	US5357042 Synthetic peptides capable of eliciting fibrin-specific monoclonal antibodies lacking fibrinogen-cross-reactivity
10/18/1994	US5356613 X-ray contrast agents, compositions and methods
10/13/1994	WO1994022811A1 New non ionic iodine-containing dimers useful as x-ray contrast agents, method for the preparation thereof, and galenical compositions containing them
10/13/1994	WO1994022810A1 New non-ionic iodine-containing dimers useful as x-rays contrast agents, method for the preparation thereof, and galenical compositions containing them
10/13/1994	WO1994022494A1 RADIOLABELED PLATELET GPIIb/IIIa RECEPTOR ANTAGONISTS AS IMAGING AGENTS FOR THE DIAGNOSIS OF THROMBOEMBOLIC DISORDERS
10/13/1994	WO1994022493A1 Chelators of type xn1s1x' for radioactive isotopes, their metal complexes and their diagnostic and therapeutical uses
10/13/1994	WO1994022490A1 Conjugates of proteins and bifunctional ligands
10/13/1994	WO1994022484A1 Directed delivery of radioprotectants using a receptor specific carrier
10/13/1994	WO1994022460A1 Diagnosis and treatment of erectile dysfunction
10/13/1994	WO1994022368A1 Perfluoro-1h-1h-neopentyl containing contrast agents and method to use same

1 ... 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 ... 354